D. Communi

发表

Cotranscription and Intergenic Splicing of HumanP2Y 11 and SSF1 Genes*

J. Boeynaems, D. Communi, N. Suarez-Huerta, 2001, The Journal of Biological Chemistry.

ATP confers tumorigenic properties to dendritic cells by inducing amphiregulin secretion.

J. Boeynaems, D. Communi, N. Bles, 2010, Blood.

Synthesis and Structure−Activity Relationships of Suramin-Derived P2Y11 Receptor Antagonists with Nanomolar Potency

G. Schmalzing, J. Boeynaems, M. Kassack, 2005 .

NF546 [4,4′-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-α,α′-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells

G. Schmalzing, J. Boeynaems, A. Hamacher, 2010, Journal of Pharmacology and Experimental Therapeutics.

The fate of P2Y-related orphan receptors: GPR80/99 and GPR91 are receptors of dicarboxylic acids

J. Boeynaems, D. Communi, Nathalie Suarez Gonzalez, 2004, Purinergic Signalling.

Overview of the P2 receptors.

J. Boeynaems, D. Communi, B. Robaye, 2005, Seminars in thrombosis and hemostasis.

P2Y receptors in dendritic cells: from inflammation to tolerance

D. Communi, B. Robaye, 2013 .

Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells.

M. Goldman, J. Boeynaems, D. Communi, 2005, Blood.

Loss of Mouse P2Y4 Nucleotide Receptor Protects against Myocardial Infarction through Endothelin-1 Downregulation

J. Balligand, C. Dessy, C. Beauloye, 2015, The Journal of Immunology.

through Endothelin-1 Downregulation Protects against Myocardial Infarction Nucleotide Receptor 4 Loss of Mouse P2Y

J. Balligand, C. Dessy, C. Beauloye, 2022 .

of extracellular ATP in human dendritic cells Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets

M. Goldman, D. Communi, D. Communi, 2013 .

Gene Expression Profiling Defines ATP as a Key Regulator of Human Dendritic Cell Functions

J. Boeynaems, F. Libert, D. Communi, 2007 .

Mouse P2Y4 Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation.

J. Boeynaems, D. Communi, M. Horckmans, 2017, Stem cells and development.

Running Head : P 2 Y 4 regulates formation of cardiac adipose tissue Mouse P 2 Y 4 nucleotide receptor is a negative regulator of cardiac adipose-derived stem cell differentiation and cardiac fat formation

J. Boeynaems, D. Communi, M. Horckmans, 2016 .

Extracellular nucleotides induce COX-2 up-regulation and prostaglandin E2 production in human A549 alveolar type II epithelial cells.

B. Marcet, J. Boeynaems, F. Libert, 2007, European journal of pharmacology.

Connection Between Cardiac Vascular Permeability, Myocardial Edema, and Inflammation During Sepsis: Role of the &agr;1AMP-Activated Protein Kinase Isoform

B. Viollet, B. Gerber, S. Germain, 2013, Critical care medicine.

P2Y 4 , P2Y 6 and P2Y 11 receptors: From the early days of cloning to their function Biochemical

J. Boeynaems, D. Communi, M. Horckmans, 2020 .

P2Y2 Nucleotide Receptor Is a Regulator of the Formation of Cardiac Adipose Tissue and Its Fat-Associated Lymphoid Clusters.

D. Communi, M. Horckmans, Irene Negri, 2019, Stem cells and development.

Extracellular nucleotides regulate CCL20 release from human primary airway epithelial cells, monocytes and monocyte‐derived dendritic cells

B. Marcet, J. Boeynaems, S. Hassid, 2007, Journal of cellular physiology.

Gene deletion of P2Y4 receptor lowers exercise capacity and reduces myocardial hypertrophy with swimming exercise.

J. Balligand, C. Dessy, J. Boeynaems, 2012, American journal of physiology. Heart and circulatory physiology.

P2Y4 nucleotide receptor: a novel actor in post-natal cardiac development

J. Balligand, C. Dessy, C. Gachet, 2012, Angiogenesis.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases

P. Durez, J. Rasschaert, D. Communi, 2020, Scandinavian journal of rheumatology.

Extracellular adenine nucleotides inhibit the release of major monocyte recruiters by human monocyte‐derived dendritic cells

M. Parmentier, B. Marcet, J. Boeynaems, 2006, FEBS letters.

Cloning and Functional Expression of a Human Uridine Nucleotide Receptor (*)

M. Parmentier, S. Pirotton, J. Boeynaems, 1995, The Journal of Biological Chemistry.

Pharmacological characterization of the human P2Y13 receptor.

J. Boeynaems, D. Communi, D. Communi, 2003, Molecular pharmacology.

Pharmacological characterization of the human P2Y11 receptor

J. Boeynaems, D. Communi, B. Robaye, 1999, British journal of pharmacology.

P2Y6 Nucleotide Receptor Mediates Monocyte Interleukin-8 Production in Response to UDP or Lipopolysaccharide*

S. Soltoff, J. Sévigny, S. Robson, 2001, The Journal of Biological Chemistry.

Extracellular nucleotides and interleukin-8 production by ARPE cells: potential role of danger signals in blood-retinal barrier activation.

B. Marcet, C. Bruyns, J. Boeynaems, 2009, Investigative ophthalmology & visual science.

Modulation of inflammation by extracellular nucleotides.

J. Boeynaems, D. Communi, 2006, The Journal of investigative dermatology.

Nucleotide receptor P2Y13

J. Boeynaems, D. Communi, B. Robaye, 2006 .

Nucleotide receptor P2Y4

J. Boeynaems, D. Communi, B. Robaye, 2005 .

Central role of PD-L1 in cardioprotection resulting from P2Y4 nucleotide receptor loss

D. Communi, M. Horckmans, Esteban Diaz Villamil, 2022, Frontiers in Immunology.

Coexpression of P2Y and P2U receptors on aortic endothelial cells. Comparison of cell localization and signaling pathways.

E. Raspé, S. Pirotton, J. Boeynaems, 1995, Circulation research.

Overview of P2Y receptors as therapeutic targets

J. Boeynaems, D. Communi, N. Suarez-Huerta, 2001 .

Overview of the pharmacology and physiological roles of P2Y receptors

J. Boeynaems, D. Communi, B. Robaye, 2012 .

Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy*

J. Balligand, C. Beauloye, J. Boeynaems, 2016, The Journal of Biological Chemistry.

Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor*

D. Weissman, Houping Ni, K. Karikó, 2002, The Journal of Biological Chemistry.

Protective Role of P2Y2 Receptor against Lung Infection Induced by Pneumonia Virus of Mice

J. Boeynaems, D. Communi, D. Desmecht, 2012, PloS one.

Advances in signalling by extracellular nucleotides. the role and transduction mechanisms of P2Y receptors.

J. Boeynaems, D. Communi, N. Suarez-Huerta, 2000, Cellular signalling.

Nucleotide Receptors Coupling to the Phospholipase C Signaling Pathway

S. Pirotton, J. Boeynaems, D. Communi, 1998 .

Expression of P2Y receptors in cell lines derived from the human lung

M. Parmentier, J. Boeynaems, D. Communi, 1999, British journal of pharmacology.

Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl Cyclase*

Marc Parmentier, M. Parmentier, J. Boeynaems, 1997, The Journal of Biological Chemistry.

Molecular mechanisms of extracellular adenine nucleotides-mediated inhibition of human Cd4+ T lymphocytes activation

M. Goldman, J. Boeynaems, D. Communi, 2005, Purinergic Signalling.

Extracellular Adenine Nucleotides Inhibit the Activation of Human CD4+ T Lymphocytes1

M. Goldman, C. Bruyns, J. Boeynaems, 2002, The Journal of Immunology.

Identification of a Novel Human ADP Receptor Coupled to Gi *

M. Parmentier, J. Boeynaems, V. Lannoy, 2001, The Journal of Biological Chemistry.

P2Y4, P2Y6 and P2Y11 receptors : from the early days of cloning to their function.

J. Boeynaems, D. Communi, M. Horckmans, 2020, Biochemical pharmacology.

Modulation of murine dendritic cell function by adenine nucleotides and adenosine: Involvement of the A2B receptor

X. Hua, C. Ledent, J. Boeynaems, 2008, European journal of immunology.

Gene Expression Profiling Defines ATP as a Key Regulator of Human Dendritic Cell Functions1

J. Boeynaems, H. El Housni, F. Libert, 2007, The Journal of Immunology.

Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte‐derived dendritic cells

J. Boeynaems, D. Communi, F. Marteau, 2004, Journal of leukocyte biology.

Rapid up‐regulation of P2Y messengers during granulocytic differentiation of HL‐60 cells

J. Boeynaems, D. Communi, B. Robaye, 2000, FEBS letters.

P2Y2R Deficiency Attenuates Experimental Autoimmune Uveitis Development

C. Bruyns, J. Boeynaems, D. Communi, 2015, PloS one.

Coexpression of Several Types of Metabotropic Nucleotide Receptors in Single Cerebellar Astrocytes

J. Boeynaems, D. Communi, E. Castro, 2000, Journal of neurochemistry.

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Christoph Dehio, Danica Stanimirovic, Lieve Moons, 2003, Nature Medicine.

Cloning of a human heptahelical receptor closely related to the P2Y5 receptor.

J. Boeynaems, D. Communi, R Janssens, 1997, Biochemical and biophysical research communications.

Receptors responsive to extracellular uracil nucleotides

M. Parmentier, J. Boeynaems, D. Communi, 1998 .

P2Y2 Receptor Regulates VCAM-1 Membrane and Soluble Forms and Eosinophil Accumulation during Lung Inflammation

J. Boeynaems, D. Communi, M. Horckmans, 2010, The Journal of Immunology.

P2Y4 nucleotide receptor: a novel actor in post-natal cardiac development

J. Balligand, C. Dessy, C. Gachet, 2012, Angiogenesis.

Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis

J. Ruidavets, L. Martinez, D. Communi, 2022, Frontiers in Pharmacology.

UTP is a regulator of in vitro and in vivo angiogenic properties of cardiac adipose–derived stem cells

D. Communi, M. Horckmans, Larissa di Pietrantonio, 2021, Purinergic Signalling.

P2Y receptors: New subtypes, new functions

J. Boeynaems, D. Communi, P. Savi, 2003 .

Role of P2Y11 receptors in hematopoiesis

J. Boeynaems, D. Communi, B. Robaye, 2001 .

Pharmacological characterization of the human P2Y4 receptor.

S. Pirotton, J. Boeynaems, D. Communi, 1996, European journal of pharmacology.

Cloning and tissue distribution of the human P2Y1 receptor.

M. Parmentier, S. Pirotton, J. Boeynaems, 1996, Biochemical and biophysical research communications.

Cloning, functional expression and tissue distribution of the human P2Y6 receptor.

M. Parmentier, J. Boeynaems, D. Communi, 1996, Biochemical and biophysical research communications.

Slow desensitization of the human P2Y6 receptor.

J. Boeynaems, D. Communi, D. Communi, 1997, European journal of pharmacology.

Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy*

J. Balligand, C. Beauloye, J. Boeynaems, 2016, The Journal of Biological Chemistry.

Involvement of multiple receptors in the actions of extracellular ATP: the example of vascular endothelial cells.

S. Pirotton, J. Boeynaems, D. Communi, 1995, The international journal of biochemistry & cell biology.

UTP Regulates the Cardioprotective Action of Transplanted Stem Cells Derived From Mouse Cardiac Adipose Tissue

D. Communi, Marion Vanorlé, Esteban Diaz Villamil, 2022, Frontiers in Pharmacology.

Receptors responsive to extracellular pyrimidine nucleotides.

J. Boeynaems, D. Communi, D. Communi, 1997, Trends in pharmacological sciences.

G. Schmalzing, J. Boeynaems, A. Hamacher, 2010, Journal of Pharmacology and Experimental Therapeutics.

Gene deletion of P2Y4 receptor lowers exercise capacity and reduces myocardial hypertrophy with swimming exercise.

J. Balligand, C. Dessy, J. Boeynaems, 2012, American journal of physiology. Heart and circulatory physiology.